Chadban SJ - Search Results

1

Historical controlled trial of OKT3 versus basiliximab induction therapy in simultaneous pancreas-renal transplantation.

Chow FY, Polkinghorne K, Saunder A, Kerr PG, Atkins RC, Chadban SJ. Chow FY, et al. Among authors: chadban sj. Nephrology (Carlton). 2003 Aug;8(4):212-6. doi: 10.1046/j.1440-1797.2003.00158.x. Nephrology (Carlton). 2003. PMID: 15012723 Clinical Trial.

2

Interleukin-10 is a mesangial cell growth factor in vitro and in vivo.

Chadban SJ, Tesch GH, Foti R, Atkins RC, Nikolic-Paterson DJ. Chadban SJ, et al. Lab Invest. 1997 May;76(5):619-27. Lab Invest. 1997. PMID: 9166281

3

Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats.

Chadban SJ, Tesch GH, Lan HY, Atkins RC, Nikolic-Paterson DJ. Chadban SJ, et al. Kidney Int. 1997 Jun;51(6):1809-17. doi: 10.1038/ki.1997.248. Kidney Int. 1997. PMID: 9186870 Free article.

4

Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidney.

Tesch GH, Yang N, Yu H, Lan HY, Foti R, Chadban SJ, Atkins RC, Nikolic-Paterson DJ. Tesch GH, et al. Among authors: chadban sj. Nephrol Dial Transplant. 1997 Jun;12(6):1109-15. doi: 10.1093/ndt/12.6.1109. Nephrol Dial Transplant. 1997. PMID: 9198037

5

Interleukin-10 differentially modulates MHC class II expression by mesangial cells and macrophages in vitro and in vivo.

Chadban SJ, Tesch GH, Foti R, Lan HY, Atkins RC, Nikolic-Paterson DJ. Chadban SJ, et al. Immunology. 1998 May;94(1):72-8. doi: 10.1046/j.1365-2567.1998.00487.x. Immunology. 1998. PMID: 9708189 Free PMC article.

6

PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.

Gilbert RE, Kelly DJ, McKay T, Chadban S, Hill PA, Cooper ME, Atkins RC, Nikolic-Paterson DJ. Gilbert RE, et al. Kidney Int. 2001 Apr;59(4):1324-32. doi: 10.1046/j.1523-1755.2001.0590041324.x. Kidney Int. 2001. PMID: 11260393 Free article.

7

Urine macrophage migration inhibitory factor concentrations as a diagnostic tool in human renal allograft rejection.

Brown FG, Nikolic-Paterson DJ, Chadban SJ, Dowling J, Jose M, Metz CN, Bucala R, Atkins RC. Brown FG, et al. Among authors: chadban sj. Transplantation. 2001 Jun 27;71(12):1777-83. doi: 10.1097/00007890-200106270-00013. Transplantation. 2001. PMID: 11455258

8

Leukocyte phenotype and function predicts infection risk in renal transplant recipients.

Blazic M, Hutchinson P, Holdsworth S, Atkins RC, Chadban SJ. Blazic M, et al. Among authors: chadban sj. Transplant Proc. 2001 Nov-Dec;33(7-8):3651. doi: 10.1016/s0041-1345(01)02572-6. Transplant Proc. 2001. PMID: 11750551 No abstract available.

9

Macrophage colony-stimulating factor expression and macrophage accumulation in renal allograft rejection.

Le Meur Y, Jose MD, Mu W, Atkins RC, Chadban SJ. Le Meur Y, et al. Among authors: chadban sj. Transplantation. 2002 Apr 27;73(8):1318-24. doi: 10.1097/00007890-200204270-00022. Transplantation. 2002. PMID: 11981428

10

Risk of renal allograft loss from recurrent glomerulonephritis.

Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ. Briganti EM, et al. Among authors: chadban sj. N Engl J Med. 2002 Jul 11;347(2):103-9. doi: 10.1056/NEJMoa013036. N Engl J Med. 2002. PMID: 12110738 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters